Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Meetings
Meetings
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
7th IASLC Latin American Conference on Lung Cancer
lungcanc
2017 Lung Cancer SPORE Workshop
ELCC 2017 Unveils New Research Regarding Screening, Immunotherapy, Treatment Planning, and More
Lung Cancer 360 Forum Overview: C.A.I.R.O Journal Club’s Fourth Anniversary
Highlights from IASLC WCLC 2016
5th AACR-IASLC International Joint Conference: Translational Progress through Basic Research
lungcanc
Studies Indicate Expanding Benefit of Checkpoint Inhibitors
lungcanc
Targeted Therapies Meeting Focuses on Upcoming Research Advances in Lung Cancer
lungcanc
ELCC 2017 Unveils New Research Regarding Screening, Immunotherapy, Treatment Planning, and...
lungcanc
Best of IASLC WCLC 2016
lungcanc
Best of the 16th World Conference on Lung Cancer in Peru
lungcanc
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
lungcanc
Prior Pneumonitis as a Risk Factor for Treatment-Associated Pneumonitis With Immune...
lungcanc
IASLC’s Inaugural Mesothelioma Meeting Sets Baseline for Strategic Approach to Patient...
lungcanc
Best of the 16th WCLC in Athens, Greece
lungcanc
1
2
3
...
6
Page 1 of 6
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS